AB-101
IRIS-RD-01
Phase 1 small_molecule active
Quick answer
AB-101 for Rheumatoid Arthritis is a Phase 1 program (small_molecule) at Artiva Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Artiva Biotherapeutics
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active